Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter
Phase 2
Completed
- Conditions
- Respiratory Tract Infection
- Registration Number
- NCT00688610
- Lead Sponsor
- Hannover Medical School
- Brief Summary
Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter.
The purpose of this study is to compare the ordinary manner of antibiotic- prescription with the prescription in consideration of procalcitonin-value in patients with acute respiratory tract infections.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 571
Inclusion Criteria
- 18 years or older
- Informed consent
- Respiratory tract infection based on the clinical judgement of the primary care physician
Exclusion Criteria
- Antibiotic pretreatment in previous 14 days
- Portal hypertension
- Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
- Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
- Peritoneal dialysis
- Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
- Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method days with significant impairment due to acute respiratory tract infection 14 to 28 days after infection
- Secondary Outcome Measures
Name Time Method number of antibiotic prescriptions 28 days
Trial Locations
- Locations (1)
Medical School Hannover, Department Pneumology
🇩🇪Hannover, Germany